Sarepta Therapeutics | SRPT - 贷款资金



金融业
股票价格
USD
资产
USD 3.35B
现金及等价物
USD 801.28M
销售成本
USD 399.39M
流动资产
USD 2.54B
流动负债
USD 1.1B
债务
USD 1.25B
EBIT
USD -410.08M
EBITDA
USD -168.03M
员工
1.37K
EPS每股收益
USD -3.58
股本和储备
USD 1.14B
销售毛利
USD 43.55M
债务利息支出
USD 7.56M
利息收入
USD 8.38M
贷款资金
USD 828.97M
市值
USD 1.98B
净收入
USD -412.23M
营业费用
USD 853.02M
营业利润
USD -410.08M
普通股股本
USD 104.96M
PE价格收益
27.27
税前利润
USD -407.68M
销售收入
USD 442.9M
销售和管理费用
USD 105.38M
股票
USD 914.74M
贸易债权人
USD 280.84M
应收帐款人
USD 398.23M


贷款资金 更改 日
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Amgen USD 50B 2.43B 2025-12
BioCryst Pharmaceuticals USD 428.67M 234.31M 2025-12
Biogen USD 6.29B 1.7M 2026-03
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Capricor Therapeutics USD 3.38M 0 2025-03
Daiichi Sankyo JPY 300.15B 199.41B 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Gilead Sciences USD 22.13B 6M 2025-12
Incyte USD 29.41M 785K 2026-03
Insmed USD 540.96M 1.24M 2025-12
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
Moderna USD 610M 584M 2025-12
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novavax USD 246.3M 200K 2025-12
Pfizer USD 57.41B 93M 2025-09
PTC Therapeutics USD 2.03B 193.22M 2025-12
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 13.84B 1.88B 2026-03
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Tectonic Therapeutic USD 43K 57K 2025-12
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03